William S. Brooks

7.6k total citations
61 papers, 2.7k citations indexed

About

William S. Brooks is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, William S. Brooks has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Physiology, 18 papers in Neurology and 16 papers in Molecular Biology. Recurrent topics in William S. Brooks's work include Alzheimer's disease research and treatments (38 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Dementia and Cognitive Impairment Research (11 papers). William S. Brooks is often cited by papers focused on Alzheimer's disease research and treatments (38 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Dementia and Cognitive Impairment Research (11 papers). William S. Brooks collaborates with scholars based in Australia, United States and United Kingdom. William S. Brooks's co-authors include Glenda M. Halliday, G. Anthony Broe, Helen Creasey, Peter R. Schofield, John B. Kwok, Ralph N. Martins, John T. Galambos, David Grayson, Christopher Fisher and J. Harasty and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

William S. Brooks

61 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S. Brooks Australia 31 1.4k 727 661 553 442 61 2.7k
Per‐Göran Gillberg Sweden 31 885 0.6× 704 1.0× 420 0.6× 318 0.6× 219 0.5× 79 2.6k
Rachel S. Mulligan Australia 33 2.1k 1.5× 686 0.9× 622 0.9× 1.9k 3.4× 355 0.8× 82 4.2k
Yoshio Ikeda Japan 28 636 0.5× 914 1.3× 810 1.2× 204 0.4× 428 1.0× 136 2.8k
Annachiara Cagnin Italy 23 1.1k 0.8× 749 1.0× 1.2k 1.7× 512 0.9× 1.3k 3.0× 59 3.5k
Sun Hyung Joo South Korea 17 3.1k 2.3× 1.7k 2.4× 539 0.8× 1.1k 2.1× 551 1.2× 44 5.1k
Suzanne de la Monte United States 26 789 0.6× 1.5k 2.1× 433 0.7× 143 0.3× 253 0.6× 55 3.2k
Jiong Shi United States 27 1.1k 0.8× 813 1.1× 217 0.3× 492 0.9× 492 1.1× 79 2.9k
Seppo Helisalmi Finland 38 2.5k 1.8× 1.2k 1.6× 670 1.0× 1.3k 2.3× 736 1.7× 132 4.5k
Liying Han China 21 1.4k 1.0× 943 1.3× 256 0.4× 420 0.8× 587 1.3× 51 3.2k
Zsuzsanna Nagy United Kingdom 38 1.6k 1.2× 1.3k 1.8× 402 0.6× 748 1.4× 466 1.1× 90 3.8k

Countries citing papers authored by William S. Brooks

Since Specialization
Citations

This map shows the geographic impact of William S. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Brooks more than expected).

Fields of papers citing papers by William S. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Brooks. The network helps show where William S. Brooks may publish in the future.

Co-authorship network of co-authors of William S. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Brooks. A scholar is included among the top collaborators of William S. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Brooks. William S. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weickert, Thomas W., Isabella Jacomb, Rhoshel Lenroot, et al.. (2023). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain Behavior and Immunity. 115. 191–200. 17 indexed citations
2.
Cairns, Nigel J., Richard J. Perrin, Erin Franklin, et al.. (2015). Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). PMC. 2 indexed citations
3.
Dobson‐Stone, Carol, Marianne Hallupp, Clement T. Loy, et al.. (2013). C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients. PLoS ONE. 8(2). e56899–e56899. 37 indexed citations
4.
Luty, Agnes A., John B. Kwok, Elizabeth M. Thompson, et al.. (2008). Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurology. 8(1). 32–32. 58 indexed citations
5.
Gnjec, Anastazija, Simon M. Laws, Kevin Taddei, et al.. (2008). Association of alleles carried at TNFA -850 and BAT1-22 with Alzheimer's disease. Journal of Neuroinflammation. 5(1). 36–36. 23 indexed citations
6.
Huang, Yue, Mike Hayes, Antony J. Harding, et al.. (2006). Anticipation of onset age in familial Parkinson's disease without SCA gene mutations. Parkinsonism & Related Disorders. 12(5). 309–313. 3 indexed citations
7.
Harding, Antony J., Anurina Das, Jillian J. Kril, et al.. (2004). Identification of families with cortical Lewy body disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 128B(1). 118–122. 12 indexed citations
8.
Stanford, Prudence M., William S. Brooks, Erdahl Teber, et al.. (2004). Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies. Journal of Neurology. 251(9). 1098–104. 38 indexed citations
9.
Brooks, William S.. (2003). Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions. Brain. 126(4). 783–791. 45 indexed citations
10.
Miklossy, Judith, Kevin Taddei, Domizio Suvà, et al.. (2003). Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer’s disease. Neurobiology of Aging. 24(5). 655–662. 39 indexed citations
11.
Piguet, Olivier, David Grayson, Helen Creasey, et al.. (2003). Vascular Risk Factors, Cognition and Dementia Incidence over 6 Years in the Sydney Older Persons Study. Neuroepidemiology. 22(3). 165–171. 80 indexed citations
12.
Taddei, Kevin, Christopher Fisher, Simon M. Laws, et al.. (2002). Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population. Molecular Psychiatry. 7(7). 776–781. 24 indexed citations
13.
Broe, G. Anthony, David Grayson, Helen Creasey, et al.. (2000). Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses. Archives of Neurology. 57(11). 1586–91. 131 indexed citations
14.
Milward, Elizabeth A., David Grayson, Helen Creasey, et al.. (1999). Evidence for association of anaemia with vascular dementia. Neuroreport. 10(11). 2377–2381. 34 indexed citations
15.
Laws, Simon M., Kevin Taddei, Georgia Martins, et al.. (1999). The —491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimerʼs disease. Neuroreport. 10(4). 879–882. 63 indexed citations
16.
Yang, Jiao, et al.. (1996). Apolipoprotein E genotyping in Alzheimer's disease in an Australian sample. Australian and New Zealand Journal of Medicine. 26(5). 658–661. 6 indexed citations
17.
Harasty, J., Glenda M. Halliday, Chris Code, & William S. Brooks. (1996). Quantification of cortical atrophy in a case of progressive fluent aphasia. Brain. 119(1). 181–190. 63 indexed citations
18.
Maltby, N, G. Anthony Broe, Helen Creasey, et al.. (1994). Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial. BMJ. 308(6933). 879–883. 62 indexed citations
19.
Martins, Ralph N., et al.. (1993). Plasma amyloid precursor protein is decreased in Alzheimerʼs disease. Neuroreport. 4(6). 757–759. 13 indexed citations
20.
Halliday, Glenda M., Heather McCann, Roger Pamphlett, et al.. (1992). Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathologica. 84(6). 638–50. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per‐Göran Gillberg Breakdown of academic impact, for papers by Rachel S. Mulligan Breakdown of academic impact, for papers by Yoshio Ikeda Breakdown of academic impact, for papers by Annachiara Cagnin Breakdown of academic impact, for papers by Sun Hyung Joo Breakdown of academic impact, for papers by Suzanne de la Monte Breakdown of academic impact, for papers by Jiong Shi Breakdown of academic impact, for papers by Seppo Helisalmi Breakdown of academic impact, for papers by Liying Han Breakdown of academic impact, for papers by Zsuzsanna Nagy
Rankless by CCL
2026